Provided by Tiger Trade Technology Pte. Ltd.

Teladoc Health Inc.

5.67
-0.1300-2.24%
Post-market: 5.720.0484+0.85%19:06 EDT
Volume:3.42M
Turnover:19.58M
Market Cap:1.03B
PE:-5.71
High:5.93
Open:5.87
Low:5.65
Close:5.80
52wk High:9.89
52wk Low:4.40
Shares:181.65M
Float Shares:180.76M
Volume Ratio:0.99
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9925
EPS(LYR):-1.1400
ROE:-12.99%
ROA:-3.22%
PB:0.79
PE(LYR):-4.97

Loading ...

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
2 hours ago

Teladoc announces resignation of CLO Vandervoort, Dorfman to succeed

TIPRANKS
·
Sep 25

Teladoc Names Jonathan Dorfman Chief Legal Officer, Succeeding Adam Vandervoort

Reuters
·
Sep 25

Press Release: Teladoc Health Announces Chief Legal Officer Transition

Dow Jones
·
Sep 25

Labcorp Holdings Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 25

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Teladoc (TDOC) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Sep 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) and Oscar Health (OSCR)

TIPRANKS
·
Sep 16

Labcorp Holdings Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 15

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 05

Teladoc Grants Incoming CFO Michael Grasher 239,616 RSUs, 239,616 Target PSUs as Inducement Award

Reuters
·
Sep 04

Press Release: Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303a.08

Dow Jones
·
Sep 04

Teladoc BetterHelp President Fernando M. Rodrigues Sells TDOC Shares Worth $98,912.16

Reuters
·
Sep 04

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Teladoc Files Form 3 for CFO Michael F. Grasher

Reuters
·
Sep 02

What Teladoc Health (TDOC)'s New Insurance-Focused CFO Appointment Means For Shareholders

Simply Wall St.
·
Sep 02

Teladoc Buy Rating Reaffirmed as New CFO Appointment Stabilizes Leadership; $10 Price Target Maintained

TIPRANKS
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Sep 01

Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment

TIPRANKS
·
Sep 01

Teladoc Appoints Insurance Executive Michael Grasher as CFO

Reuters
·
Aug 31